Peter Marks Peter (Jim Lo Scalzo/Pool via AP Images)
Internal documents shed new light on Sarepta FDA decision, which top agency official says was ‘exceptional’
While he has repeatedly advocated for accelerated gene therapy approvals, the FDA’s top cell and gene therapy official Peter Marks said that the agency’s landmark …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.